122 related articles for article (PubMed ID: 15927706)
41. Nerve growth factor increases connexin43 phosphorylation and gap junctional intercellular communication.
Cushing P; Bhalla R; Johnson AM; Rushlow WJ; Meakin SO; Belliveau DJ
J Neurosci Res; 2005 Dec; 82(6):788-801. PubMed ID: 16302187
[TBL] [Abstract][Full Text] [Related]
42. The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age.
Dimitrijević M; Stanojević S; Mitić K; Kustrimović N; Vujić V; Miletić T; Kovacević-Jovanović V
Peptides; 2008 Dec; 29(12):2179-87. PubMed ID: 18805447
[TBL] [Abstract][Full Text] [Related]
43. Using U0126 to dissect the role of the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade in the regulation of gene expression by endothelin-1 in cardiac myocytes.
Kennedy RA; Kemp TJ; Sugden PH; Clerk A
J Mol Cell Cardiol; 2006 Aug; 41(2):236-47. PubMed ID: 16756989
[TBL] [Abstract][Full Text] [Related]
44. Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain.
Dumont Y; Moyse E; Fournier A; Quirion R
J Pharmacol Exp Ther; 2005 Oct; 315(1):99-108. PubMed ID: 15947033
[TBL] [Abstract][Full Text] [Related]
45. Bone marrow stromal cells attenuate injury-induced changes in galanin, NPY and NPY Y1-receptor expression after a sciatic nerve constriction.
Coronel MF; Musolino PL; Brumovsky PR; Hökfelt T; Villar MJ
Neuropeptides; 2009 Apr; 43(2):125-32. PubMed ID: 19168218
[TBL] [Abstract][Full Text] [Related]
46. Self-regulation of agonist activity at the Y receptors.
Parker SL; Parker MS; Sah R; Balasubramaniam A; Sallee FR
Peptides; 2007 Feb; 28(2):203-13. PubMed ID: 17194507
[TBL] [Abstract][Full Text] [Related]
47. Internalization of neuropeptide Y Y1 and Y5 and of pancreatic polypeptide Y4 receptors is inhibited by lithium in preference to sodium and potassium ions.
Parker MS; Parker SL; Kane JK
Regul Pept; 2004 Apr; 118(1-2):67-74. PubMed ID: 14759559
[TBL] [Abstract][Full Text] [Related]
48. Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells.
Poomthavorn P; Wong SH; Higgins S; Werther GA; Russo VC
Endocr Relat Cancer; 2009 Sep; 16(3):991-1004. PubMed ID: 19423615
[TBL] [Abstract][Full Text] [Related]
49. Enhanced ERK dependent CREB activation reduces apoptosis in staurosporine-treated human neuroblastoma SK-N-BE(2)C cells.
Park EM; Cho S
Neurosci Lett; 2006 Jul; 402(1-2):190-4. PubMed ID: 16678346
[TBL] [Abstract][Full Text] [Related]
50. Autocrine and paracrine signaling through neuropeptide receptors in human cancer.
Heasley LE
Oncogene; 2001 Mar; 20(13):1563-9. PubMed ID: 11313903
[TBL] [Abstract][Full Text] [Related]
51. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression.
Ngan ES; Sit FY; Lee K; Miao X; Yuan Z; Wang W; Nicholls JM; Wong KK; Garcia-Barcelo M; Lui VC; Tam PK
Clin Cancer Res; 2007 Feb; 13(3):868-75. PubMed ID: 17289879
[TBL] [Abstract][Full Text] [Related]
52. Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC.
Fabry M; Langer M; Rothen-Rutishauser B; Wunderli-Allenspach H; Höcker H; Beck-Sickinger AG
Eur J Biochem; 2000 Sep; 267(17):5631-7. PubMed ID: 10951224
[TBL] [Abstract][Full Text] [Related]
53. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
[TBL] [Abstract][Full Text] [Related]
54. Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors.
O'Hare MM; Schwartz TW
Cancer Res; 1989 Dec; 49(24 Pt 1):7010-4. PubMed ID: 2582442
[TBL] [Abstract][Full Text] [Related]
55. GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system.
Lindner D; van Dieck J; Merten N; Mörl K; Günther R; Hofmann HJ; Beck-Sickinger AG
Biochemistry; 2008 Jun; 47(22):5905-14. PubMed ID: 18457425
[TBL] [Abstract][Full Text] [Related]
56. Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist.
Dautzenberg FM; Higelin J; Pflieger P; Neidhart W; Guba W
Neuropharmacology; 2005 Jun; 48(7):1043-55. PubMed ID: 15857631
[TBL] [Abstract][Full Text] [Related]
57. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors.
Teixeira L; Sousa DM; Nunes AF; Sousa MM; Herzog H; Lamghari M
J Cell Biochem; 2009 Aug; 107(5):908-16. PubMed ID: 19459152
[TBL] [Abstract][Full Text] [Related]
58. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
[TBL] [Abstract][Full Text] [Related]
59. Involvement of neuropeptide Y Y1 receptors in the regulation of LH and GH cells in the pituitary of the catfish, Clarias batrachus: an immunocytochemical study.
Mazumdar M; Lal B; Sakharkar AJ; Deshmukh M; Singru PS; Subhedar N
Gen Comp Endocrinol; 2006 Nov; 149(2):190-6. PubMed ID: 16828090
[TBL] [Abstract][Full Text] [Related]
60. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family.
Zou C; Kumaran S; Markovic S; Walser R; Zerbe O
Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
